TYLENOL® Future Care Scholarship Will Support 40 Students Pursuing Degrees in Healthcare

FOR IMMEDIATE RELEASE

Ft. Washington, PA, April 15, 2013 – McNeil Consumer Healthcare Division of McNEIL-PPC, Inc., the makers of TYLENOL®, announces the 23nd annual TYLENOL® Future Care Scholarship program. The 2013 program will again award a total of $250,000 in scholarship funds to 40 undergraduate or graduate students pursuing careers in healthcare. Winners will be named TYLENOL® Future Care Scholars and receive awards of $5,000 or $10,000 to help manage the rising costs of education.

“The TYLENOL® brand is deeply committed to caring for people who are committed to caring for others,” said Denice Torres, President, McNeil Consumer Healthcare. “To date, our TYLENOL® Future Care Scholarship program has awarded more than $8.9 million in scholarship funds to more than 6,700 students embarking on a variety of diverse career paths in the healthcare field.”

TYLENOL® Future Care Scholars will be selected based on leadership qualities, academic performance and community involvement. To be eligible, students must complete at least one year of undergraduate or graduate study by the Spring of 2013 at an accredited two or four year college, university or vocational/technical school.

The application period is now open and submissions must be received by June 15, 2013. Scholarship award decisions will be made in July and awards distributed in August.

To learn more or apply visit: www.Tylenol.com/Scholarship. Join the conversation on Facebook: www.facebook.com/TylenolScholarship. Sign up for SMS reminders by texting SCHOLAR to 87715.

About McNeil Consumer Healthcare
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. markets a broad range of well-known and trusted over-the-counter (OTC) products around the globe. McNeil Consumer Healthcare is most widely recognized for the TYLENOL® brand. Other McNeil Consumer Healthcare brands include BENADRYL®, ZYRTEC® and ZYRTEC®-D allergy medicines, IMODIUM® A-D anti-diarrheal, MOTRIN® IB pain reliever and fever reducer, and SUDAFED® and SUDAFED PE® nasal decongestants.

Media Contacts:
Janine Berstein
Tel: (646) 489-1770
Email: jberstein@mac.com

Holly Derrick
McNeil Consumer Healthcare
Tel: 215 273-7923
Email: hderrick@its.jnj.com

###